• About
• Links
• Contact
• Sitemap
• 

The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand

Summary

The report provides key data, information and analysis on the global in-vitro diagnostics market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories - Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis.

Scope

Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Belgium, Netherlands, Japan, China, India, Australia, Taiwan, republic of Korea, Brazil, Argentina, Mexico, Israel and South Africa.

Global Market size and company share data for seven In-Vitro Diagnostics market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture and haematology.

Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.

Qualitative analysis of key market trends, market drivers and restraints by categories and segments.

Competitive landscape and key company profiles. Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson (BD), Bio-Rad Laboratories, Inverness Medical Innovations, Sysmex, Gen-Probe and Dade Behring.

Key in-pipeline products and technologies expected to hit the global In-Vitro Diagnostics market in the near future.

Reasons to buy

Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market globally.

Design and develop your product development, marketing and sales strategies.

Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies.

Identify key players best positioned to take advantage of the emerging market opportunities.

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

What’s the next big thing in the In-Vitro Diagnostics market landscape? – Identify, understand and capitalize

Make more informed business decisions from the insightful and in-depth analysis of the In-Vitro Diagnostics market and the factors shaping it.

Table of Contents

1 Table of Contents 3

• 1.1 List of Tables 7
• 1.2 List of Figures 9

2 Introduction and Overview 11

• 2.1 In-Vitro-Diagnostics (IVD) Overview 11

3 Global In-Vitro Diagnostics (IVD) Market: Market Characterization 12

• 3.1 Global In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 12
• 3.2 Global In-Vitro Diagnostics (IVD) Market, Revenue Forecasts ($m), 2009 – 2016 13
• 3.3 Global In-Vitro Diagnostics (IVD) Market, Company Share (%), 2008 14
• 3.4 Global In-Vitro Diagnostics (IVD) Market, Key Market Trends 15
  • 3.4.1 Entry of Diagnostic Imaging Players into the In-Vitro Diagnostics (IVD) Market Has Set Stage for New Technologies to Be Developed By Marrying the Two Disciplines 15
  • 3.4.2 Large Number of Private Equity/ Venture Capital (PE/VC) Investments and Collaborations in the In-Vitro Diagnostics (IVD) Sector to Fuel Innovation 16
  • 3.4.3 Consolidation of Laboratories across the World 16
• 3.5 Global In-Vitro Diagnostics (IVD) Market: Key Technology Trends 17
  • 3.5.1 Emerging Technologies for Cutting Lab Costs 17
  • 3.5.2 New Technologies Improve Speed and Accuracy 18
• 3.6 Global In-Vitro Diagnostics (IVD) Market, Market Drivers 20
  • 3.6.1 Economic Market Drivers 20
  • 3.6.2 Technological Market Drivers 22
  • 3.6.3 Regulatory Market Drivers 22
  • 3.6.4 Social Market Drivers 22
• 3.7 In-Vitro Diagnostics (IVD) Market, Market Restraints 23
  • 3.7.1 Economic Market Restraints 23
  • 3.7.2 Social Market Restraints 24

4 Global In-Vitro Diagnostics (IVD) Market: Category Analysis and Forecasts 25

• 4.1 Clinical Chemistry Market: Market Characterization 25
  • 4.1.1 Global Clinical Chemistry Market, Revenue ($m), 2002–2009 25
  • 4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009–2016 26
  • 4.1.3 Global Clinical Chemistry Market, Company Share (%), 2008 27
  • 4.1.4 Clinical Chemistry Market: Market Drivers 28
  • 4.1.5 Clinical Chemistry Market: Market Restraints 28
• 4.2 Immuno Chemistry Market: Market Characterization 29
  • 4.2.1 Global Immuno Chemistry Market, Revenue ($m), 2002 – 2009 29
  • 4.2.2 Global Immuno Chemistry Market, Revenue Forecast ($m), 2009 – 2016 31
  • 4.2.3 Global Immuno Chemistry Market, Company Share (%), 2008 32
  • 4.2.4 Immuno Chemistry Market: Market Drivers 33
  • 4.2.5 Immuno Chemistry Market: Market Restraints 34
• 4.3 Haematology Market: Market Characterization 35
  • 4.3.1 Global Haematology Market, Revenues ($m), 2002 – 2009 35
  • 4.3.2 Global Haematology Market, Revenue Forecasts ($m), 2009 – 2016 36
  • 4.3.3 Global Haematology Market, Company Share (%), 2008 37
  • 4.3.4 Haematology Market: Market Drivers 37
  • 4.3.5 Haematology Market: Market Restraints 38
• 4.4 Histology and Cytology Market: Market Characterization 39
  • 4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002 – 2009 39
  • 4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m), 2009 – 2016 40
  • 4.4.3 Global Histology and Cytology Market, Company Share (%), 2008 41
  • 4.4.4 Histology and Cytology Market: Market Drivers 42
  • 4.4.5 Histology and Cytology Market: Market Restraints 42
• 4.5 Microbiology Culture Market: Market Characterization 43
  • 4.5.1 Global Microbiology Culture Market, Revenue ($m), 2002 – 2009 43
  • 4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009 – 2016 44
  • 4.5.3 Global Microbiology Culture Market, Company Share (%), 2008 45
  • 4.5.4 Global Microbiology Culture Market: Market Drivers 45
  • 4.5.5 Microbiology Culture Market: Market Restraints 46
• 4.6 Infectious Immunology Market: Market Characterization 47
  • 4.6.1 Global Infectious Immunology Market, Revenue ($m), 2002 – 2009 47
  • 4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m), 2009 – 2016 48
  • 4.6.3 Global Infectious Immunology Market, Company Share (%), 2008 49
  • 4.6.4 Global Infectious Immunology Market: Market Drivers 49
  • 4.6.5 Global Infectious Immunology Market: Market Restraints 50
• 4.7 Genetic Testing Market: Market Characterization 51
  • 4.7.1 Global Genetic Testing Market, Revenue ($m), 2002 – 2009 51
  • 4.7.2 Global Genetic Testing Market, Revenue Forecasts ($m), 2009 – 2016 52
  • 4.7.3 Global Genetic Testing Market, Company Share (%), 2008 53
  • 4.7.4 Global Genetic Testing Market: Market Drivers 53
  • 4.7.5 Global Genetic Testing Market: Market Restraints 54

5 Global In-Vitro Diagnostics (IVD) Market: Country Analysis and Forecasts 55

• 5.1 Global In-Vitro Diagnostics (IVD)Market: Geographic Trends Analysis 55
• 5.2 Market Characterization, North America, 2002 – 2016 56
  • 5.2.1 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 56
  • 5.2.2 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 57
  • 5.2.3 Canada In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 58
  • 5.2.4 North America In-Vitro Diagnostics (IVD) Market, Market Drivers 60
  • 5.2.5 North America In-Vitro Diagnostics (IVD) Market, Market Restraints 60
• 5.3 Market Characterization, Europe, 2002 – 2016 61
  • 5.3.1 The UK In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 61
  • 5.3.2 The UK In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 – 2016 62
  • 5.3.3 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 63
  • 5.3.4 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 64
  • 5.3.5 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 65
  • 5.3.6 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 67
  • 5.3.7 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 68
  • 5.3.8 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 69
  • 5.3.9 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 70
  • 5.3.10 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 71
  • 5.3.11 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 72
  • 5.3.12 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 73
  • 5.3.13 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 74
  • 5.3.14 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 75
  • 5.3.15 Europe In-Vitro Diagnostics (IVD) Market, Market Drivers 76
  • 5.3.16 Europe In-Vitro Diagnostics (IVD) Market, Market Restraints 76
• 5.4 Market Characterization, Asia Pacific, 2002 – 2016 77
  • 5.4.1 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 77
  • 5.4.2 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 78
  • 5.4.3 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 79
  • 5.4.4 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 81
  • 5.4.5 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 82
  • 5.4.6 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 83
  • 5.4.7 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 84
  • 5.4.8 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 85
  • 5.4.9 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 86
  • 5.4.10 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 87
  • 5.4.11 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 88
  • 5.4.12 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 89
  • 5.4.13 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Drivers 90
  • 5.4.14 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Restraints 91
• 5.5 Market Characterization, South and Central America, 2002 – 2016 91
  • 5.5.1 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 91
  • 5.5.2 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 93
  • 5.5.3 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 94
  • 5.5.4 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 95
  • 5.5.5 Mexico In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 96
  • 5.5.6 Mexico In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 – 2016 97
  • 5.5.7 South and Central America In-Vitro Diagnostics (IVD) Market, Market Drivers 98
  • 5.5.8 South and Central America In-Vitro Diagnostics (IVD) Market, Market Restraints 98
• 5.6 Market Characterization, Middle East and Africa, 2002 – 2016 99
  • 5.6.1 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 99
  • 5.6.2 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 100
  • 5.6.3 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 101
  • 5.6.4 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 102
  • 5.6.5 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Drivers 103
  • 5.6.6 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Restraints 103

6 Global In-Vitro Diagnostics (IVD) Market: Strategic Competitive Assessment 104

• 6.1 Key Market Participants 104
  • 6.1.1 F. Hoffmann-La Roche Ltd 104
  • 6.1.2 Siemens Medical Solutions 106
  • 6.1.3 Abbott Laboratories 108
  • 6.1.4 Beckman Coulter, Inc. 110
  • 6.1.5 bioMerieux Sa 113
  • 6.1.6 Ortho-Clinical Diagnostics 114
  • 6.1.7 Becton, Dickinson and Company 115
  • 6.1.8 Bio-Rad Laboratories, Inc. 116
  • 6.1.9 Inverness Medical Innovations, Inc 117

7 Global In-Vitro Diagnostics (IVD) Market: Product Pipeline Analysis 120

• 7.1 Pipeline Products Analysis by Category 120
  • 7.1.1 Pipeline Products Analysis: Immuno Chemistry Market 121
  • 7.1.2 Pipeline Products Analysis: Infectious Immunology 122
• 7.2 Key Pipeline Products Currently Undergoing Development 122
  • 7.2.1 Clinical Chemistry Pipeline Products 122
  • 7.2.2 Genetic Testing 122
  • 7.2.3 Haematology 123
  • 7.2.4 Immunochemistry 124
  • 7.2.5 Infectious Immunology 125
  • 7.2.6 Microbiology Culture 126
  • 7.2.7 Histology and Cytology 126

8 Global In-Vitro Diagnostics (IVD) Market: Consolidation Landscape 127

• 8.1 Deals by Type, 2006 – 2009 127
• 8.2 Deals by Value and Volume, 2006 – 2009 128
• 8.3 List of Deals in 2009 128
• 8.4 Top 10 Acquisitions By Value, 2009 131
  • 8.4.1 Agilent Technologies Receives Shareholders Approval To Acquire Varian 131
  • 8.4.2 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 131
  • 8.4.3 MDS Receives Shareholder Approval To Sell MDS Analytical Technologies To Danaher 132
  • 8.4.4 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S. 132
  • 8.4.5 Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital 132
  • 8.4.6 Becton, Dickinson and Company Completes Acquisition Of HandyLab 133
  • 8.4.7 Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn 133
  • 8.4.8 Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 133
  • 8.4.9 Gen-Probe Acquires Tepnel Life Sciences 134

9 Appendix 135

• 9.1 Definitions 135
  • 9.1.1 Clinical Chemistry 135
  • 9.1.2 Immunochemistry Test Reagents 136
  • 9.1.3 Haematology 137
  • 9.1.4 Histology And Cytology 138
  • 9.1.5 Microbiology Culture 139
  • 9.1.6 Infectious Immunology 139
  • 9.1.7 Genetic Testing 140
• 9.2 Acronyms 140
• 9.3 Methodology 140
  • 9.3.1 Secondary Research 141
  • 9.3.2 Primary Research 141
  • 9.3.3 Models 142
  • 9.3.4 Forecasts 142
  • 9.3.5 Expert Panels 142
• 9.4 Contact Us 142
• 9.5 Disclaimer 142

1.1 List of Tables

• Table 1: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2002-2009 12
• Table 2: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2009-2016 13
• Table 3: In-Vitro Diagnostics (IVD) Market, Global, Company Share ($m), 2008 14
• Table 4: Clinical Chemistry Market, Global, Revenue ($m), 2002–2009 25
• Table 5: Clinical Chemistry Market, Global, Revenue ($m), 2009–2016 26
• Table 6: Clinical Chemistry Market, Global, Company Share ($m), 2008 27
• Table 7: Immuno Chemistry Market, Global, Revenue ($m), 2002–2009 30
• Table 8: Immuno Chemistry Market, Global, Revenue ($m), 2009–2016 31
• Table 9: Immuno Chemistry Market, Global, Company Share ($m), 2008 32
• Table 10: Haematology Market, Global, Revenues ($m), 2002–2009 35
• Table 11: Haematology Market, Global, Revenue ($m), 2009–2016 36
• Table 12: Haematology Market, Global, Company Share ($m), 2008 37
• Table 13: Histology and Cytology Market, Global, Revenue ($m), 2002–2009 39
• Table 14: Histology and Cytology Market, Global, Revenue ($m), 2009–2016 40
• Table 15: Histology and Cytology Market, Global, Company Share ($m), 2008 41
• Table 16: Microbiology Culture Market, Global, Revenue ($m), 2002–2009 43
• Table 17: Microbiology Culture Market, Global, Revenue ($m), 2009–2016 44
• Table 18: Microbiology Culture Market, Global, Company Share ($m), 2008 45
• Table 19: Infectious Immunology Market, Global, Revenue ($m), 2002–2009 47
• Table 20: Infectious Immunology Market, Global, Revenue ($m), 2009–2016 48
• Table 21: Infectious Immunology Market, Global, Company Share ($m), 2008 49
• Table 22: Genetic Testing Market, Global, Revenue ($m), 2002–2009 51
• Table 23: Genetic Testing Market, Global, Revenue ($m), 2009–2016 52
• Table 24: Global Genetic Testing Market, Global, Company Share ($m), 2008 53
• Table 25: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2002-2009 56
• Table 26: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2009-2016 57
• Table 27: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2002-2009 58
• Table 28: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2009-2016 59
• Table 29: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2002-2009 61
• Table 30: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2009-2016 62
• Table 31: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2002-2009 63
• Table 32: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2009-2016 64
• Table 33: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2002-2009 66
• Table 34: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2009-2016 67
• Table 35: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2002-2009 68
• Table 36: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2009-2016 69
• Table 37: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2002-2009 70
• Table 38: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2009-2016 71
• Table 39: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2002-2009 72
• Table 40: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2009-2016 73
• Table 41: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2002-2009 74
• Table 42: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2009-2016 75
• Table 43: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2002-2009 77
• Table 44: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2009-2016 78
• Table 45: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2002-2009 80
• Table 46: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2009-2016 81
• Table 47: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009 82
• Table 48: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009 83
• Table 49: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2002-2009 85
• Table 50: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2009-2016 86
• Table 51: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2002-2009 87
• Table 52: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2009-2016 88
• Table 53: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2002-2009 89
• Table 54: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2009-2016 90
• Table 55: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2002-2009 92
• Table 56: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2009-2016 93
• Table 57: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2002-2009 94
• Table 58: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2009-2016 95
• Table 59: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2002-2009 96
• Table 60: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2009-2016 97
• Table 61: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2002-2009 99
• Table 62: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2009-2016 100
• Table 63: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2002-2009 101
• Table 64: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2009-2016 102
• Table 65: Roche’s Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 104
• Table 66: Roche In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 105
• Table 67: Siemens Medical Solutions In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 107
• Table 68: Siemen’s Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 108
• Table 69: Abbott Laboratories’ Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 109
• Table 70: Abbott Laboratories In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 110
• Table 71: Beckman Coulter’s Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 112
• Table 72: Beckman Coulter, Inc. In-Vitro Diagnostics (IVD) Pipeline Products 113
• Table 73: bioMerieux’s Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 114
• Table 74: bioMerieux Sa, In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 114
• Table 75: Ortho-Clinical Diagnostics, In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 115
• Table 76: Becton Dickinson, Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 116
• Table 77: Becton, Dickinson Inc. In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 116
• Table 78: Bio-Rad, Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 117
• Table 79: Inverness Medical Innovations, Inc., Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 118
• Table 80: Inverness Medical Innovations In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 119
• Table 81: In-Vitro Diagnostics (IVD) Market, Global, Pipeline Products by Category, 2009 120
• Table 82: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009 121
• Table 83: Infectious Immunology Market, Global, 2009 122
• Table 84: Deals By Type, Global In-Vitro Diagnostics (IVD) Market, 2006-2009 127
• Table 85: Key Deals, Global In-Vitro Diagnostics (IVD) Market, 2009 128

1.2 List of Figures

• Figure 1: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2002-2009 12
• Figure 2: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2009-2016 13
• Figure 3: In-Vitro Diagnostics (IVD) Market, Global, Company Share (%), 2008 14
• Figure 4: Global In-Vitro Diagnostics (IVD) Market: Key Market Trends 15
• Figure 5: Global Laboratory Consolidation Landscape, 2005–2009 16
• Figure 6: Global In Vitro Diagnostics Market: Key Technology Trends 17
• Figure 7: Global In-Vitro Diagnostics (IVD) Market: Drivers and Restraints 19
• Figure 8: List of Retail Clinics in the US and Diagnostic In-Vitro Diagnostics (IVD) Tests Offered 21
• Figure 9: Clinical Chemistry Market, Global, Revenue ($m), 2002–2009 25
• Figure 10: Clinical Chemistry Market, Global, Revenue ($m), 2009–2016 26
• Figure 11: Clinical Chemistry Market, Global, Company Share (%), 2008 27
• Figure 12: Immuno Chemistry Market, Global, Revenue ($m), 2002–2009 29
• Figure 13: Immuno Chemistry Market, Global, Revenue ($m), 2009–2016 31
• Figure 14: Immuno Chemistry Market, Global, Company Share (%),2008 32
• Figure 15: Haematology Market, Global, Revenue ($m), 2002–2009 35
• Figure 16: Haematology Market, Global, Revenue ($m), 2009–2016 36
• Figure 17: Haematology Market, Global, Company Share (%), 2008 37
• Figure 18: Histology and Cytology Market, Global, Revenue ($m), 2002–2009 39
• Figure 19: Histology and Cytology Market, Global, Revenue ($m), 2009–2016 40
• Figure 20: Histology and Cytology Market, Global, Company Share (%), 2008 41
• Figure 21: Microbiology Culture Market, Global, Revenue ($m), 2002–2009 43
• Figure 22: Microbiology Culture Market, Global, Revenue ($m), 2009–2016 44
• Figure 23: Microbiology Market, Global, Company Share (%),2008 45
• Figure 24: Infectious Immunology Market, Global, Revenue ($m), 2002–2009 47
• Figure 25: Infectious Immunology Market, Global, Revenue ($m), 2009–2016 48
• Figure 26: Infectious Immunology Market, Global, Company Share (%), 2008 49
• Figure 27: Genetic Testing Market, Global, Revenue ($m), 2002–2009 51
• Figure 28: Genetic Testing Market, Global, Revenue ($m), 2009–2016 52
• Figure 29: Global Genetic Testing Market, Global, Company Share (%),2008 53
• Figure 30: In-Vitro Diagnostics (IVD) Market, Global, Geographic Trends Analysis 55
• Figure 31: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2002-2009 56
• Figure 32: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2009-2016 57
• Figure 33: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2002-2009 58
• Figure 34: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2009-2016 59
• Figure 35: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2002-2009 61
• Figure 36: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2009-2016 62
• Figure 37: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2002-2009 63
• Figure 38: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2009-2016 64
• Figure 39: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2002-2009 65
• Figure 40: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2009-2016 67
• Figure 41: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2002-2009 68
• Figure 42: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2009-2016 69
• Figure 43: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2002-2009 70
• Figure 44: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2009-2016 71
• Figure 45: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2002-2009 72
• Figure 46: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2009-2016 73
• Figure 47: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2002-2009 74
• Figure 48: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2009-2016 75
• Figure 49: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2002-2009 77
• Figure 50: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2009-2016 78
• Figure 51: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2002-2009 79
• Figure 52: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2009-2016 81
• Figure 53: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009 82
• Figure 54: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009 83
• Figure 55: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2002-2009 84
• Figure 56: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2009-2016 85
• Figure 57: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2002-2009 86
• Figure 58: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2009-2016 87
• Figure 59: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2002-2009 88
• Figure 60: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2009-2016 89
• Figure 61: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2002-2009 91
• Figure 62: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2009-2016 93
• Figure 63: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2002-2009 94
• Figure 64: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2009-2016 95
• Figure 65: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2002-2009 96
• Figure 66: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2009-2016 97
• Figure 67: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2002-2009 99
• Figure 68: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2009-2016 100
• Figure 69: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2002-2009 101
• Figure 70: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2009-2016 102
• Figure 71: In-Vitro Diagnostics (IVD) Market, Global, Pipeline Products Analysis by Category, 2009 120
• Figure 72: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009 121
• Figure 73: Infectious Immunology Market, Global, 2009 122
• Figure 74: Deals By Type, Global In-Vitro Diagnostics (IVD) Market, 2006-2009 127
• Figure 75: Deals By Value and Volume, Global In-Vitro Diagnostics (IVD) Market, Value ($m), 2006-2009 128
• Figure 76: Research Methodology 141

Other users found this report page using the following search terms: In Vitro Diagnostics IVD market diagnostics vitro diagnostic uk value acquisitions invitro future ivd

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.